<- Go Home
Galderma Group AG
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Market Cap
CHF 51.7B
Volume
717.5K
Cash and Equivalents
CHF 780.0M
EBITDA
CHF 1.1B
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
CHF 3.6B
Profit Margin
68.86%
52 Week High
CHF 227.11
52 Week Low
CHF 139.82
Dividend
0.20%
Price / Book Value
6.35
Price / Earnings
85.48
Price / Tangible Book Value
-31.95
Enterprise Value
CHF 53.7B
Enterprise Value / EBITDA
45.87
Operating Income
CHF 885.0M
Return on Equity
7.69%
Return on Assets
4.25
Cash and Short Term Investments
CHF 780.0M
Debt
CHF 2.8B
Equity
CHF 8.1B
Revenue
CHF 5.2B
Unlevered FCF
CHF 1.0B
Sector
Pharmaceuticals
Category
N/A